TGFB1 and cancer: To avoid cell contamination in the organoid preparations, Nanki et al. established a new method to enrich the cancer organoids by inhibiting various signals, i.e., RAS-phosphoinositide 3-kinase (PI3K), RHO, TGFβ, TP53 which are not tolerated by nonmutated normal organoids [49].